We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$26.1B
AUM Growth
+$1.03B
Cap. Flow
-$146M
Cap. Flow %
-0.56%
Top 10 Hldgs %
13.61%
Holding
1,470
New
112
Increased
493
Reduced
531
Closed
130

Top Buys

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$94.2M
2
MDT icon
Medtronic
MDT
+$83.5M
3
VZ icon
Verizon
VZ
+$54.1M
4
ADBE icon
Adobe
ADBE
+$54.1M
5
AMZN icon
Amazon
AMZN
+$50.7M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$81.3M
2
ST icon
Sensata Technologies
ST
+$78M
3
PCG icon
PG&E
PCG
+$52M
4
AMGN icon
Amgen
AMGN
+$43.5M
5
LOW icon
Lowe's Companies
LOW
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 22.67%
2 Healthcare 15.83%
3 Consumer Discretionary 11.21%
4 Financials 11.2%
5 Industrials 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCOM
1151
DELISTED
Dime Community Bancshares
DCOM
$411K ﹤0.01%
21,100
-8,800
-29% -$173K
URBN icon
1152
Urban Outfitters
URBN
$6.55B
$410K ﹤0.01%
+9,200
New +$385K
IHC
1153
DELISTED
Independence Holding Company
IHC
$408K ﹤0.01%
12,256
LII icon
1154
Lennox International
LII
$12.5B
$402K ﹤0.01%
+2,012
New +$408K
PRTA icon
1155
Prothena Corp
PRTA
$431M
$400K ﹤0.01%
27,460
-115,421
-81% -$2.28M
QDEL icon
1156
QuidelOrtho
QDEL
$748M
$399K ﹤0.01%
6,000
-142,403
-96% -$8.6M
MGNX icon
1157
MacroGenics
MGNX
$259M
$396K ﹤0.01%
+19,200
New +$432K
LGLV icon
1158
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.2B
$391K ﹤0.01%
4,340
+80
+2% +$7.2K
EMKR
1159
DELISTED
Emcore Corp
EMKR
$391K ﹤0.01%
7,751
AMC icon
1160
AMC Entertainment Holdings
AMC
$2.22B
$385K ﹤0.01%
2,420
LEN icon
1161
Lennar Class A
LEN
$19.3B
$384K ﹤0.01%
7,554
-223
-3% -$11.7K
FIT
1162
DELISTED
Fitbit, Inc. Class A common stock
FIT
$376K ﹤0.01%
+57,600
New +$329K
RDNT icon
1163
RadNet
RDNT
$6.24B
$375K ﹤0.01%
25,000
+14,800
+145% +$201K
ADEA icon
1164
Adeia
ADEA
$2.76B
$370K ﹤0.01%
+86,940
New +$469K
CPF icon
1165
Central Pacific Financial
CPF
$971M
$370K ﹤0.01%
12,900
FEZ icon
1166
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.34B
$370K ﹤0.01%
9,664
-10,300
-52% -$418K
FRT icon
1167
Federal Realty Investment Trust
FRT
$9.87B
$370K ﹤0.01%
2,925
+73
+3% +$8.62K
VNO icon
1168
Vornado Realty Trust
VNO
$6.51B
$370K ﹤0.01%
5,000
-4,716
-49% -$326K
TUR icon
1169
iShares MSCI Turkey ETF
TUR
$217M
$368K ﹤0.01%
12,184
EZPW icon
1170
Ezcorp Inc
EZPW
$1.87B
$366K ﹤0.01%
+30,400
New +$398K
GWW icon
1171
W.W. Grainger
GWW
$60.1B
$361K ﹤0.01%
1,171
-365
-24% -$109K
VEGI icon
1172
iShares MSCI Agriculture Producers ETF
VEGI
$174M
$359K ﹤0.01%
12,600
EWM icon
1173
iShares MSCI Malaysia ETF
EWM
$314M
$357K ﹤0.01%
11,464
MYOK
1174
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$357K ﹤0.01%
7,200
-101,528
-93% -$4.92M
IGOV icon
1175
iShares International Treasury Bond ETF
IGOV
$1.53B
$356K ﹤0.01%
7,230
-600
-8% -$29.9K

Similar funds

Axa's Q2 2018 Portfolio in Review

As of Q2 2018, Axa held 1,470 positions worth $26.1B, up 4.1% from $25.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2018 filing shows 112 new, 493 increased, 531 reduced and 130 closed positions. Its largest new stake was Foot Locker: 289,100 shares worth $15.2M. The largest sale was AbbVie, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2018 buy was Foot Locker: 289,100 shares worth $15.2M.
  • Axa added most to TE Connectivity in Q2 2018, an estimated $94.2M increase.
  • Axa's biggest Q2 2018 reduction was AbbVie, cutting an estimated $81.3M.
  • Axa fully exited PG&E in Q2 2018, selling an estimated $52M.
  • Axa's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2018.
  • Axa opened 112 new positions and closed 130 in Q2 2018.
  • Axa's portfolio value rose 4.1% quarter-over-quarter to $26.1B.

Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.